| Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes H Shafi, DVS Reddy, T Khan, R Ranjan, A Srivastava, S Vaishya, ... International Journal of Pharmaceutics 524 (1-2), 205-214, 2017 | 17 | 2017 |
| Transient transfection of the respiratory epithelium with gamma interferon for host-directed therapy in pulmonary tuberculosis R Bharti, A Srivastava, T Roy, K Verma, DVS Reddy, H Shafi, S Verma, ... Molecular Therapy Nucleic Acids 22, 1121-1128, 2020 | 11 | 2020 |
| Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics D Datta, SP Bandi, V Colaco, N Dhas, DVS Reddy, LK Vora International Journal of Pharmaceutics, 124192, 2024 | 9 | 2024 |
| Super disintegrating oromucosal nanofiber patch of zolmitriptan for rapid delivery and efficient brain targeting H Shafi, R Rashid, S Rather, DVS Reddy, L Azmi, A Abdal-hay, ... Chemical Engineering Journal 463, 142481, 2023 | 9 | 2023 |
| Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis R Bharti, T Roy, S Verma, DVS Reddy, H Shafi, K Verma, SK Raman, ... Tuberculosis 134, 102198, 2022 | 8 | 2022 |
| A quality by design approach for developing SNEDDS loaded with vemurafenib for enhanced oral bioavailability C Jvus, N Kothuri, S Singh, S Verma, H Shafi, DVS Reddy, A Kedar, ... AAPS PharmSciTech 25 (1), 14, 2024 | 6 | 2024 |
| Inhaled Adjunct therapy with second-line drug candidates for dose reduction in chemotherapeutic regimens for multi-drug-resistant tuberculosis S Verma, NJK Dal, A Srivastava, R Bharti, DV Siva Reddy, HS Sofi, T Roy, ... AAPS PharmSciTech 24 (5), 130, 2023 | 6 | 2023 |
| Effect of Temperature and Thermodynamics of Adsorption of Isoproturon on some soils of Hyderabed S Raman, DS Reddy J. Indian Soc. Soil Sci. 35, 298-300, 1987 | 6 | 1987 |
| Preparation and evaluation of low-dose calcitriol dry powder inhalation as host-directed adjunct therapy for tuberculosis DVS Reddy, H Shafi, R Bharti, T Roy, S Verma, SK Raman, K Verma, ... Pharmaceutical Research 39 (10), 2621-2633, 2022 | 5 | 2022 |
| Factors affecting the pharmacokinetics of the liposomal drugs S Polaka, K Katrajkar, DVS Reddy, H Shukla, B Arafat, RK Tekade Biopharmaceutics and Pharmacokinetics Considerations, 567-599, 2021 | 4 | 2021 |
| Optimizing the fabrication of electrospun nanofibers of prochlorperazine for enhanced dissolution and permeation properties H Shafi, DVS Reddy, R Rashid, T Roy, S Kawoosa, GN Bader, ... Biomaterials Advances 158, 213773, 2024 | 3 | 2024 |
| Plant-derived synthesis of bionanomaterials L Azmi, DVS Reddy, S Pal Synthesis of bionanomaterials for biomedical applications, 131-150, 2023 | 3 | 2023 |
| Comparative Preclinical Pharmacokinetics and Disposition of Favipiravir Following Pulmonary and Oral Administration as Potential Adjunct Therapy Against Airborne RNA Viruses VSR Devireddy, H Shafi, S Verma, S Singh, J Chakradhar, N Kothuri, ... Pharmaceutical Research, 1-10, 2024 | 2 | 2024 |
| Transcriptional regulation of suppressors of cytokine signaling during infection with Mycobacterium tuberculosis in human THP-1-derived macrophages and in mice T Roy, A Seth, H Shafi, DVS Reddy, SK Raman, J Chakradhar, S Verma, ... Microbes and Infection 26 (3), 105282, 2024 | 2 | 2024 |
| Dry Powder Inhalation of Lytic Mycobacteriophages for Adjunct Therapy in a Mouse Model of Infection with Mycobacterium tuberculosis S kumar Raman, T Roy, K Verma, C Yadav, S Verma, VSR Devireddy, ... Authorea Preprints, 2024 | 1 | 2024 |
| Mycobacteriophages: therapeutic approach for mycobacterial infections SK Raman, DVS Reddy, V Jain, U Bajpai, A Misra, AK Singh Drug Discovery Today, 104049, 2024 | 1 | 2024 |
| Correction: Preparation and Evaluation of Low-Dose Calcitriol Dry Powder Inhalation as Host-Directed Adjunct Therapy for Tuberculosis DVS Reddy, H Shaf, R Bharti, T Roy, S Verma, SK Raman, K Verma, ... Pharmaceutical Research 39 (11), 3039, 2022 | 1 | 2022 |
| Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol K Verma, T Garg, S Singh, VSR Deivreddy, SK Raman, R Bharti, HS Sofi, ... Tuberculosis 151, 102606, 2025 | | 2025 |
| Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical … R Ranjan, VSR Devireddy Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2024 | | 2024 |
| Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathology AM D.V. Siva Reddy, Hasham Shafi Sofi, Trisha Roy, Sonia Verma, Kaveri R ... Tuberculosis 148 (102536), 2024 | | 2024 |
Amit MisraScientist, CSIR-Central Drug Research Institute, Lucknow, IndiaBestätigte E-Mail-Adresse bei cdri.res.in